Israeli imaging analysis software developer CathWorks said that results from a pivotal trial evaluating its FFRangio fractional flow reserve (FFR) analysis software will be presented at the 2018 Transcatheter Cardiovascular Therapeutics (TCT) annual meeting in September in San Diego.
The trial, called FFRangio Accuracy vs. Standard FFR (FAST-FFR), was designed to evaluate the sensitivity and specificity of FFRangio compared with conventional invasive FFR at 10 cardiovascular centers around the world, according to CathWorks. Data from FAST-FFR will be presented in the late-breaking clinical science program on September 24.
In addition, the firm's system will be the focus of a TCT lunch presentation theater program, which will also be held on September 24, the company said.
![Axial images from unenhanced calcium score cardiac CT (left) and curved planar reformation images from CT angiography (right) show that higher long-term exposure to air pollution is associated with greater coronary artery calcium and more obstructive coronary artery disease (CAD). Top row: Images in a 68-year-old male patient with higher 10-year mean ambient air pollution exposure (7.9 μg/m3 for particulate matter measuring ≤2.5 μm in diameter [PM2.5] and 17.4 parts per billion [ppb] for NO2) with extensive CAD (coronary artery calcium score [CACS] >1,000 and obstructive CAD [≥70% diameter stenosis]). Bottom row: Images in a 57-year-old female patient with lower 10-year mean ambient air pollution exposure (6.3 μg/m3 for PM2.5 and 4.6 ppb for NO2) with no CAD (CACS = 0 and no obstructive stenosis).](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/06/hanneman.r6SMLzkezo.png?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
